Experts have warned that Britain could be only “a few weeks away” from shortages of medicines, from everyday pain relief to cancer therapies, if the war with Iran continues. They also caution that the price of many drugs may increase. The conflict has already disrupted supplies of essential raw materials such as oil, gas, fertilisers and helium, and the pharmaceutical sector could soon feel the impact. David Weeks, director of supply chain risk management at analytics firm Moody’s, described